Government puts $96M towards helping aged care providers reduce chemical restraints in 2020-21 in response to Royal Commission Interim Report
The Government has announced it will commit $96.4 million towards the first year of medication management programs for aged care services under its Seventh Community Pharmacy Agreement (7CPA) to cut the use of antipsychotic drugs in aged care –...

The Government has announced it will commit $96.4 million towards the first year of medication management programs for aged care services under its Seventh Community Pharmacy Agreement (7CPA) to cut the use of antipsychotic drugs in aged care – one of three areas highlighted for action by the Royal Commission in last October’s Interim Report.
The Agreement – which will begin next month and be in place until 30 June 2025 – also pledges to match the $25.5 million a year announced by Prime Minister to manage medications in residential care and in home care.
Review of medication is not mandatory, so a person could go months or even years without another review.
The Agreement will also fund the reviews by a pharmacist in a person’s home.
The question is: when the pharmacist and the GP get time to get these reviews? And will aged care operators see any of the funding?